Sign in

CIK 0001816736

  • Large accelerated filer

Disc Medicine, Inc.

Sign in to watch
Ticker
IRON
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
851612845
Phone
+1 617-674-9274
Business address
321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
Former names
Gemini Therapeutics, Inc. /DE, FS Development Corp.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$11,877,065
in 6 filings, $10.0M under 10b5-1 plans

Net −$11,877,065. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 32 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-12-12 White William Richard Director Sale −4,057 $66.10 $268K 0
2023-12-12 White William Richard Director Option exercise · Stock Option (Right to Buy) −21,084 7,024
2023-12-12 White William Richard Director Option exercise · Stock Option (Right to Buy) −5,427 4,216
2023-12-12 White William Richard Director Option exercise · Stock Option (Right to Buy) −7,000 0
2023-12-12 Bryce Joanne Chief Financial Officer Option exercise 10b5-1 +2,500 $2.65 $7K 5,000
2023-12-12 Bryce Joanne Chief Financial Officer Sale 10b5-1 −2,500 $65.22 $163K 2,500
2023-12-12 Bryce Joanne Chief Financial Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −2,500 2,253
2023-12-12 ORBIMED ADVISORS LLC Director Sale −14,400 $60.16 $866K 1,182,425
2023-12-12 ORBIMED ADVISORS LLC Director Sale −9,300 $60.16 $559K 764,307
2023-12-12 ORBIMED ADVISORS LLC Director Sale −3,600 $60.16 $217K 295,605
2023-12-12 Ashiya Mona Director Sale −14,400 $60.16 $866K 1,182,425
2023-12-12 Ashiya Mona Director Sale −9,300 $60.16 $559K 764,307
2023-12-12 Ashiya Mona Director Sale −3,600 $60.16 $217K 295,605
2023-12-05 Bryce Joanne Chief Financial Officer Option exercise 10b5-1 +526 $1.01 $531 4,286
2023-12-05 Bryce Joanne Chief Financial Officer Option exercise 10b5-1 +755 $1.01 $763 5,041
2023-12-05 Bryce Joanne Chief Financial Officer Sale 10b5-1 −1,148 $55.29 $63K 3,893
2023-12-05 Bryce Joanne Chief Financial Officer Sale 10b5-1 −1,293 $56.55 $73K 2,600
2023-12-05 Bryce Joanne Chief Financial Officer Sale 10b5-1 −100 $57.06 $6K 2,500
2023-12-05 Bryce Joanne Chief Financial Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −526 0
2023-12-05 Bryce Joanne Chief Financial Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −755 752

Page 27 of 32 · 639 trades